BMS could soon face competition in the HCM space as Cytokinetics awaits a marketing application decision from the FDA for ...

According to analysts at BMO Capital Markets, non-obstructive hypertrophic cardiomyopathy would have meant a $1.3 billion ...

A study was conducted to determine the cardiopulmonary exercise characteristics of patients with diabetic cardiomyopathy and high risk for HF.

FDA approves Camzyos label update easing echo monitoring and lifting drug interaction limits, supported by 3.5 years of safety data and real-world use ...

The lack of effect on QoL and oxygen consumption help cement the idea that the disease isn’t the same as obstructive HCM.

Tina Marsden was 28 years old -- healthy and athletic -- when she gave birth to her son 22 years ago. But what followed was a medical nightmare she never saw coming.

Vutrisiran can improve and maintain functional capacity and quality of life in patients with transthyretin amyloidosis with ...

During Black Maternal Health Week (April 11-17), stories that highlight both challenges and strength of Black mothers are being uplifted. Chicago-area pastor Tracey Young’s journey stands as a ...

A retrospective analysis from Israel suggested that markers of poor hydration are linked to increased risks of hypertension ...